NICE Issues Final Guidance for Reimbursement Making VAZKEPA (icosapent ethyl) Available Across the NHS in England & Wales

13.07.2022 - - Newly published final guidance by the National Institute for Health and Care Excellence (NICE) in the UK confirms its prior draft recommendation for the use of VAZKEPA (icosapent ethyl) in England and Wales to reduce the risk of cardiovascular ... Seite 1

Related Keywords

United Kingdom , Karim Mikhail , Welsh Assembly , Health Technology Appraisal , Wales Medicines Strategy Group , Technology Appraisal , Welsh Government , All Wales Medicines Strategy Group ,